Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 7, 2022; 28(13): 1304-1314
Published online Apr 7, 2022. doi: 10.3748/wjg.v28.i13.1304
Published online Apr 7, 2022. doi: 10.3748/wjg.v28.i13.1304
Author (Yr) | n | Recurrence rate | Specific disease survival rate | Reported follow-up |
Tsikitis et al[38], 2012 | 982 | - | 95.6% | 5-yr rate |
Volante et al[17], 2013 | 138 | - | 97.1% | 86.5 mo (1 - 267) |
Mosquera et al[39], 2017 | 418 | - | 95.7% | 5-yr rate |
Sarchekeh et al[40], 2017 | 118 | - | 97.5% | 10-yr rate |
Pawa et al[41], 2017 | 215 | 0 | 99.05% | 10-yr rate |
Alexandraki et al[32], 2020 | 136 | 2.2% | 100% | 10-yr rate |
Brighi et al[5], 2020 | 435 | 0% | 98.5% | Median follow-up not provided, but at least 20% longer than 10 yr |
Alabraba et al[1], 2021 | 102 | 1% | 99% | 6.2 yr (0.8-27.8) |
Holmager et al[28], 2021 | 335 | 0% | 100% | 66 mo (1-250) |
- Citation: Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, del Olmo García MI, Barriuso J, Capdevila J, Martín-Pérez E. Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. World J Gastroenterol 2022; 28(13): 1304-1314
- URL: https://www.wjgnet.com/1007-9327/full/v28/i13/1304.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i13.1304